News

NephroCare is a comprehensive renal information system that enables care givers to electronically manage and report patient data. It integrates with other hospital and clinical systems as well

The company aims to improve existing immunoassays by providing additional sensitivity to currently available antibody-based test, as well as allowing researchers to monitor new markers that are not

Robert Pacifici, chief scientific officer of CHDI, said: “As a proven leader in the field of drug discovery, Evotec continues to be an important strategic partner in our

Bedford is expected to supply Fluconazole injection sterile iso-osmotic solution containing 2mg/ml of fluconazole in glass vials in the following presentations: Vials containing either 100mg, 200mg or 400mg

In the comparator study of 903 patients, 68% and 74% of patients receiving subcutaneous injections of Stelara (45mg or 90mg) at weeks zero and four, achieved at least

The company is currently completing Phase 2 studies of Voreloxin as a single-agent or in combination with cytarabine in acute myeloid leukemia (AML) and expects to begin Phase

Robert Wessman, executive chairman of Alvogen, said: “We see great opportunities for our business in Eastern Europe, and the creation of Alvogen Romania is integral to our development

As per the agreement, Altea and KAI are expected to examine the transdermal delivery of certain Kai proprietary compounds using Altea’s transdermal delivery technology, the PassPort System. Moreover,

Additionally, Evotec is expected to provide a full range of neurological research activities and expertise to CHDI, including integrated biology and chemistry supported by compound and library management,